Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | NKX019 |
Trade Name | |
Synonyms | NKX-019|NKX 019 |
Drug Descriptions |
NKX019 consists of natural killer cells expressing a CD19-targeting chimeric antigen receptor (CAR), which potentially results in increased killing of tumor cells expressing CD19 and reduced tumor growth (Blood (2021) 138 (Supplement 1): 23). |
DrugClasses | CD19 Immune Cell Therapy 62 |
CAS Registry Number | NA |
NCIT ID | C181804 |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
NKX019 | NKX019 | 0 | 1 |